Moderna updated clinical and supply on COVID-19 vaccine program
On Apr. 13, 2021, Moderna announced that new results from a preclinical study of the Companyメs COVID-19 variant-specific…
On Apr. 13, 2021, Moderna announced that new results from a preclinical study of the Companyメs COVID-19 variant-specific…
On Apr. 8, 2021, Oxford University announced that favipiravir was to be investigated in the UK as part…
On Mar. 31, 2021, the NIH announced that an investigational vaccine designed to protect against the B.1.351 SARS-CoV-2…
On Mar. 30, 2021, CureVac and Celonic Group announced their partnership for the production of CureVacメs mRNA-based COVID-19…
On Mar. 26, 2021, Pfizer and BioNTech announced that the European Medicines Agency (EMA) approved storage of COMIRNATYᆴ…
On Mar. 26, 2021, BioNTech announced that the European Medicines Agency (EMA) approved the manufacturing of the COVID-19…
On Mar. 26, 2021, the FDA issued an emergency use authorization (EUA) to the Twist Bioscience for their…
On Mar. 18, 2021, XPhyto and 3a-diagnostics announced the European approval of its point-of-care SARS-CoV-2 (COVID-19) RT-PCR test…
On Mar. 16, 2021, Moderna announced that the first participants had been dosed in the Phase 2/3 study,…
On Mar. 15, 2021, Twist Bioscience announced that it had started shipping its new synthetic RNA reference controls,…
On Mar. 15, 2021, Moderna announced that the first participants had been dosed in the Phase 1 study…
On Mar. 9, 2021, Agilent Technologies announced the launch of a real-time reverse transcription (qRT) PCR-based diagnostic kit…
On Mar. 5, 2021, Merck and Ridgeback Biotherapeutics, announced preliminary results from Ridgebackメs Phase 2a randomized, double-blind, placebo-controlled…
On Mar. 5, 2021, Moderna announced that Takeda Pharmaceutical had submitted a New Drug Application to the Government…
On Mar. 4, 2021, CureVac and Novartis announced an initial agreement for the manufacturing of CureVacメs COVID-19 vaccine…
On Mar. 3, 2021, Pfizer and BioNTech, in partnership with UNICEF, announced the arrival of the first doses…
On Feb. 22, 2021, Amyris announced highly promising preliminary data in a pre-clinical study of its ribonucleic acid…
On Feb. 17, 2021, BioNTech announced an agreement with the European Commission (EC) to supply an additional 200…
On Feb. 12, 2021, CureVac announced initiation of a rolling submission with the European Medicines Agency (EMA) for…
On Feb. 10, 2021, BioNTech announced they had increased their manufacturing capacity in Marburg, Germany to up to…
On Feb. 3, 2021, Moderna announced that the Singapore Health Sciences Authority (HSA) had approved the interim authorization…
On Feb. 2, 2021, GlaxoSmithKline and CureVac announced a new タ150m collaboration, building on their existing relationship, to…
On Feb. 1, 2021, Pfizer and BioNTech announced that preclinical data in non-human primate and mouse models from…
On Jan. 29, 2021, OraSure Technologies announced its OMNIgeneᆴᄋORAL (OM-505) saliva collection kit, a product of subsidiary DNA…
On Jan. 25, 2021, Moderna announced that the UKメs Medicines and Healthcare products Regulatory Agency (MHRA) had approved…
On Jan. 21, 2021, Moderna announced that the UKメs Medicines and Healthcare products Regulatory Agency (MHRA) had approved…
On Jan. 14, 2021, Twist Bioscience announced that it had started shipping its new synthetic RNA reference controls,…
On Jan. 11, 2021, Moderna announced that it was expanding its pipeline of innovative vaccines with three new…
On Jan. 8, 2021, Moderna announced announced that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) had…
On Jan. 8, 2021, BioNTech announced that it was in talks with the European Commission (EC) about an…